Product information and disease descriptionProduct descriptionProduct information
Dosing and administration
5 evidence topics · 2 sources
Atebrioz (zilurgisertib)
Fibrodysplasia ossificans progressiva
- Manufacturer
- Mirum Pharmaceuticals
- Regulatory submission
- NDA submitted by May 2026
- Last updated